{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:39:02Z","timestamp":1789915142880,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejca.2017.11.030","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T07:23:49Z","timestamp":1515655429000},"page":"30-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Paediatric dysgerminoma: Results of three consecutive French germ cell tumours clinical studies (TGM-85\/90\/95) with late effects study"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5013-7764","authenticated-orcid":false,"given":"Gw\u00e9na\u00eblle","family":"Duhil de B\u00e9naz\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Pacquement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Faure-Conter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Patte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Orbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Sudour-Bonnange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"V\u00e9rit\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7603-7828","authenticated-orcid":false,"given":"Brice","family":"Fresneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2017.11.030_bib1","unstructured":"Browse the SEER Cancer Statistics Review 1975\u20132012 [Internet]. [cited 2016 Mar 25]. Available from: http:\/\/seer.cancer.gov\/csr\/1975_2012\/browse_csr.php?sectionSEL=29&pageSEL=sect_29_table.01.html."},{"issue":"3","key":"10.1016\/j.ejca.2017.11.030_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/CEJ.0b013e32833876c0","article-title":"Incidence of childhood cancer in France: National Children Cancer Registries, 2000\u20132004","volume":"19","author":"Lacour","year":"2010","journal-title":"Eur J Cancer Prev"},{"issue":"5","key":"10.1016\/j.ejca.2017.11.030_bib3","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/01.AOG.0000216004.22588.ce","article-title":"Incidence and survival rates for female malignant germ cell tumors","volume":"107","author":"Smith","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejca.2017.11.030_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1006\/gyno.2001.6177","article-title":"Childhood malignant ovarian germ cell tumors: a monoinstitutional experience","volume":"81","author":"Terenziani","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2017.11.030_bib5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/1097-0142(197209)30:3<713::AID-CNCR2820300319>3.0.CO;2-G","article-title":"Relative frequency of ovarian neoplasms in children and adolescents","volume":"30","author":"Norris","year":"1972","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2017.11.030_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0929-693X(03)00038-1","article-title":"Gonadal tumours in children","volume":"10","author":"Martelli","year":"2003","journal-title":"Arch Pediatr"},{"issue":"3","key":"10.1016\/j.ejca.2017.11.030_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1006\/gyno.1996.0335","article-title":"Dysgerminoma: the role of conservative surgery","volume":"63","author":"Casey","year":"1996","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2017.11.030_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mpo.2950230102","article-title":"Pure dysgerminoma of the ovary in childhood: treatment results and sequelae","volume":"23","author":"Teinturier","year":"1994","journal-title":"Med Pediatr Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2017.11.030_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/mpo.2950210602","article-title":"Treatment of non-metastatic, non-seminomatous malignant germ-cell tumours in childhood: experience of the \u2018Soci\u00e9t\u00e9 Fran\u00e7aise d'Oncologie P\u00e9diatrique\u2019 MGCT 1985\u20131989 study","volume":"21","author":"Baranzelli","year":"1993","journal-title":"Med Pediatr Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2017.11.030_bib10","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1002\/pbc.25614","article-title":"Sex-cord stromal tumors in children and teenagers: results of the TGM-95 study","volume":"62","author":"Fresneau","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2017.11.030_bib11","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1200\/JCO.1999.17.4.1212","article-title":"Prognostic factors in children with localized malignant nonseminomatous germ cell tumors","volume":"17","author":"Baranzelli","year":"1999","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2017.11.030_bib12","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.suronc.2012.03.001","article-title":"Prognosis of malignant sacrococcygeal germ cell tumours according to their natural history and surgical management","volume":"21","author":"De Corti","year":"2012","journal-title":"Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2017.11.030_bib13","doi-asserted-by":"crossref","first-page":"e26494","DOI":"10.1002\/pbc.26494","article-title":"Primary mediastinal and retroperitoneal malignant germ cell tumors in children and adolescents: results of the TGM95 trial, a study of the French Society of Pediatric Oncology (Soci\u00e9t\u00e9 Fran\u00e7aise des Cancers de l'Enfant)","volume":"64","author":"Sudour-Bonnange","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2017.11.030_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mpo.2950190415","article-title":"Cisplatin ototoxicity in children: a practical grading system","volume":"19","author":"Brock","year":"1991","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ejca.2017.11.030_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"8","key":"10.1016\/j.ejca.2017.11.030_bib16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0021-9681(78)90043-7","article-title":"Estimation of confidence limits for the cumulative probability of survival in life table analysis","volume":"31","author":"Rothman","year":"1978","journal-title":"J Chronic Dis"},{"issue":"4","key":"10.1016\/j.ejca.2017.11.030_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"issue":"6","key":"10.1016\/j.ejca.2017.11.030_bib18","first-page":"605","article-title":"Conservative surgical management of malignant ovarian germ cell tumors: the experience of the Gynecologic Oncology Unit at Ain Shams University","volume":"21","author":"El-Lamie","year":"2000","journal-title":"Eur J Gynaecol Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2017.11.030_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00404-004-0601-6","article-title":"Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas","volume":"271","author":"Boran","year":"2005","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.ejca.2017.11.030_bib20","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.2001.19.4.1015","article-title":"Survival and reproductive function after treatment of malignant germ cell ovarian tumors","volume":"19","author":"Zanetta","year":"2001","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2017.11.030_bib21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1200\/JCO.1997.15.2.620","article-title":"Surveillance policy for stage I ovarian germ cell tumors","volume":"15","author":"Dark","year":"1997","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.ejca.2017.11.030_bib22","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1200\/JCO.2000.18.22.3809","article-title":"The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity","volume":"18","author":"Mann","year":"2000","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2017.11.030_bib23","first-page":"268","article-title":"Current therapy for dysgerminoma of the ovary","volume":"70","author":"Thomas","year":"1987","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejca.2017.11.030_bib24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/gyno.1995.1240","article-title":"Cisplatin-based chemotherapy in dysgerminoma of the ovary: thirteen-year experience at the Institut Gustave Roussy","volume":"58","author":"Culine","year":"1995","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2017.11.030_bib25","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/1097-0142(19910215)67:4<1084::AID-CNCR2820670436>3.0.CO;2-E","article-title":"The long-term effects of radiation therapy on patients with ovarian dysgerminoma","volume":"67","author":"Mitchell","year":"1991","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2017.11.030_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/gyno.1998.5207","article-title":"Late relapse of ovarian dysgerminoma: case report and literature review","volume":"72","author":"Bekaii-Saab","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2017.11.030_bib27","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1006\/gyno.2001.6135","article-title":"Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature","volume":"81","author":"Jeyakumar","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2017.11.030_bib28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2004.07.044","article-title":"Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group","volume":"95","author":"Williams","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2017.11.030_bib29","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1200\/JCO.1999.17.9.2670","article-title":"Outcome and reproductive function after chemotherapy for ovarian dysgerminoma","volume":"17","author":"Brewer","year":"1999","journal-title":"J Clin Oncol"},{"issue":"28","key":"10.1016\/j.ejca.2017.11.030_bib30","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1200\/JCO.2007.13.3777","article-title":"Refining the optimal chemotherapy regimen in good prognosis germ cell cancer: interpretation of the current body of knowledge","volume":"25","author":"de Wit","year":"2007","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.ejca.2017.11.030_bib31","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1200\/JCO.2004.01.006","article-title":"Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: a Pediatric Intergroup Study\u2013Pediatric Oncology Group 9048 and Children's Cancer Group 8891","volume":"22","author":"Rogers","year":"2004","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2017.11.030_bib32","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1200\/JCO.1991.9.11.1950","article-title":"Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group","volume":"9","author":"Williams","year":"1991","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2017.11.030_bib33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00043426-200009000-00007","article-title":"Malignant ovarian tumors in children: 22 years of experience at a single institution","volume":"22","author":"Aky\u00fcz","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"issue":"8763","key":"10.1016\/j.ejca.2017.11.030_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0140-6736(91)90490-G","article-title":"Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours","volume":"338","author":"Pedersen-Bjergaard","year":"1991","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.ejca.2017.11.030_bib35","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1200\/JCO.2010.28.5999","article-title":"Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial","volume":"28","author":"Le Deley","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2017.11.030_bib36","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1067\/mpd.2001.111331","article-title":"A randomized trial of treatment for multisystem Langerhans' cell histiocytosis","volume":"138","author":"Gadner","year":"2001","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.ejca.2017.11.030_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13023-017-0651-z","article-title":"Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study","volume":"12","author":"Tazi","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.ejca.2017.11.030_bib38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ygyno.2014.12.010","article-title":"Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the \u2018cisplatin era\u2019","volume":"136","author":"Solheim","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2017.11.030_bib39","first-page":"1","article-title":"Gonadal malignancy in 202 female patients with disorders of sex development containing Y-chromosome material","author":"Jiang","year":"2015","journal-title":"Gynecol Endocrinol"},{"issue":"Suppl. 2","key":"10.1016\/j.ejca.2017.11.030_bib40","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/AOG.0b013e3181e4bfe9","article-title":"Gonadal dysgenesis and gynecologic cancer","volume":"116","author":"Jonson","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejca.2017.11.030_bib41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jpurol.2011.02.021","article-title":"Dysgerminoma and gonadal dysgenesis: the need for a new diagnosis tree for suspected ovarian tumours","volume":"7","author":"Capito","year":"2011","journal-title":"J Pediatr Urol"},{"issue":"2","key":"10.1016\/j.ejca.2017.11.030_bib42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/j.1939-4640.2003.tb02672.x","article-title":"Neoplastic potential of germ cells in relation to disturbances of gonadal organogenesis and changes in karyotype","volume":"24","author":"S\u0142owikowska-Hilczer","year":"2003","journal-title":"J Androl"},{"key":"10.1016\/j.ejca.2017.11.030_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000363642","article-title":"Managing the risk of germ cell tumourigenesis in disorders of sex development patients","volume":"27","author":"Cools","year":"2014","journal-title":"Endocr Dev"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491731482X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491731482X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T15:22:09Z","timestamp":1535124129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980491731482X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":43,"alternative-id":["S095980491731482X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2017.11.030","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paediatric dysgerminoma: Results of three consecutive French germ cell tumours clinical studies (TGM-85\/90\/95) with late effects study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2017.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}